New

Insulin Pens Market

2021

Insulin Pens Market to 2027 - Global Analysis and Forecasts By Product Type (Disposable, Reusable and Smart Insulin Pen Caps); Application (Diabetes Type-1 and Diabetes Type-2); Distribution Channel (Hospital Pharmacies, Retail Pharmacies and e-Commerce) and Geography

Publication Month: Jan 2020 | Report Code: TIPRE00004650 | No. of Pages: 144 | Category: Medical Device | Status: Published

Market Insights

Insulin Pens Market to Reach US$ 8,862.0 Mn at a CAGR of 8.8% in 2027 | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The Insulin Pens in healthcare market was valued at US$ 3,957.0 million in 2018 and it is projected to reach US$ 8,286.6 million by 2027; it is expected to grow at a CAGR of 8.8% from 2019 to 2027.

Insulin Pens is a medication used along with emergency medical treatment services for the allergic reactions caused by insect bites or stings, foods, drugs, and latex, among others. It works by relaxing the muscles in the airways and tightening the blood vessels. The injection is available as a prefilled automatic injection device that contains the solution and in vials to inject subcutaneously and others. The injection is generally injected as required at the first sign of a severe allergic reaction. The growth of the Insulin Pens in healthcare market is attributed to the rising incidence of diabetes, growing geriatric population, and increasing adoption of insulin pens over conventional vials and syringes. However, the factors restraining the market growth are high cost of insulin pens and availability of alternatives to insulin pens in the market. On the other hand, high potential of market growth in the emerging economies is one of the growth opportunities for market players.

The Insulin Pens in healthcare market is expected to witness substantial growth post-pandemic. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches is also expected to pave the way for entirely virtual trials in the future. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years.

Lucrative Regions for Insulin Pens in Healthcare Market
Lucrative Regions for Insulin Pens in Healthcare Market

Get more information on this report :


Market Insights

Growing Applications of Insulin Pens in Healthcare to Drive Insulin Pens in Healthcare Market Growth

Diabetes is a life-threatening chronic disease with no specialized cure. It is mainly caused by the body’s inability to produce or effectively utilize the hormone insulin. This inability prevents the body from adequately regulating blood glucose levels. There are two types of diabetes namely diabetes type-I also known as diabetes insipidus and diabetes type-II also termed as diabetes mellitus. Incidences and prevalence of diabetes is steadily increasing across the globe. Type 2 diabetes is the most prevalent form of diabetes and has increased alongside cultural and societal changes. In high-income countries up to 91% of adults with the disease have type 2 diabetes.

According to International Diabetes Federation (IDF), approximately 425 million people were living with diabetes in

2017and it is expected to reach 629 million by 2045 across the globe. Additionally, according to BMJ Open Diabetes Research & Care, approximately 387 million patients across the globe suffer with diabetes, out of which 5-10% are victims of type-1 diabetes that require regular insulin doses. The following table represents number of patients suffering with diabetes across various regions worldwide.

Diabetes of all types can lead to various complications in many parts of the body and can increase the overall risk of premature death. Heart attack, stroke, kidney failure, leg amputation, vision loss and nerve damage are the major complications associated with this disease.

Patients suffering from diabetes require frequent monitoring and external administration of insulin that is given through insulin pens and other medical devices. The rising prevalence of diabetes across the globe is expected to drive the growth of the insulin pens market worldwide during the forecast period.

Diabetes among geriatric population is a growing public health burden worldwide. It is a major cause morbidity and mortality in ageing population that later largely attributable to various chronic complications. Ageing population is poised to become one of the most significant transformation with a heavy impact on the social and economic level across the globe. The patient population is growing exponentially worldwide. According to a report of United Nation (2017), there were approximately 962 million people aged 60 or over across the globe in 2017 and was projected to reach to 425 million by 2050. The number of geriatric population is expected to grow significantly in Africa followed by North America, Latin America & the Caribbean, and Asia Pacific region.

The elderly people are more likely to have diabetes than younger people, and the effect of the disease on quality of life is particularly deep in this population. With increase in the number of geriatric population, the prevalence of the diabetes has increased. Therefore, the demand of insulin pens, which are devices that facilitate easy administration of insulin are expected to increase in the forecast period.

In recent years, there has been a considerable developments in the field of medical drug delivery devices. Insulin administration is a common procedure in diabetic population. Traditional insulin syringes have several disadvantages that includes experience of pain by patients due to repeated pricks, discomfort in carrying both insulin bottle as well as syringe, risk of needle re-use associated infections and needle-stick injuries as well as difficulty in delivering mixture of two or more liquids together in one syringe.

Additionally, self-administration of insulin through syringes and vials is time-taking and difficult that has reduced the adoption conventional insulin injection methods over the past years and led to increased adoption of injection pens.

On the contrary, insulin pens have emerged as a solution to combat all the existing issues of the needles and vials for drug delivery offer several advantages that has led to rapid shift of patients’ preference towards their use. The injection pens that facilitates easy attachment and retraction of pen needles does not need a skill set and require fewer steps than that of syringes and vials. The pre-filled insulin syringes requires minimum steps of selecting the dose volume and attachment of pen needle which is very feasible for patients that practice self-administration of insulin on everyday basis.

Moreover, the availability of insulin in different types provide variety of options to the users to find the best suitable option according to their needs. According to a research survey published in Patient Preference and Adherence 2015, approximately 95.2% of patients participated in the survey that inject insulin regularly found pen injection method easy to use hassle-free as compared to conventional vial and syringes use. Thus, the inclination of patients towards insulin injection pens over syringes is expected to be a driving factor to foster the growth of insulin pens market.

Product Type-Based Insights

In terms of product type, the Insulin Pens in healthcare market is segmented into disposable and reusable. In 2018, the disposable segment held a largest market share of 62.6% of the insulin pens market, by product type.

Insulin Pens in Healthcare Market, by Product Type – 2018 and 2027
Insulin Pens in Healthcare Market, by Product Type – 2018 and 2027

Get more information on this report :



Application-Based Insights

Based on application, the Insulin Pens in healthcare market is segmented into diabetes type 1, and diabetes type 2. In 2018, the diabetes type-1 segment held a largest market share of 72.7% of the insulin pens market, by application.

Distribution Channel-Based Insights

In terms of distribution channel, the Insulin Pens in healthcare market is segmented into retail pharmacies, hospital pharmacies, and e commerce. In 2018, the retail pharmacies held a largest market share of 39.8% of the insulin pens market, by distribution channel and is also expected to dominate the market in 2027.

Strategic Insights

The Insulin Pens in healthcare market players are adopting the product launch and expansion strategies to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.

Insulin Pens in Healthcare Market – by Product Type

  • Disposable
  • Reusable

Insulin Pens in Healthcare Market – by Application

  • Diabetes Type-1
  • Diabetes Type-2

Insulin Pens in Healthcare Market – by Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • E-Commerce

Insulin Pens in Healthcare Market – by Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of APAC
  • Middle East & Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of MEA
  • South America and Central America (SCAM)
    • Brazil
    • Argentina
    • Rest of SCAM

Company Profiles

  • Novo Nordisk A/S
  • Owen Mumford
  • Sanofi
  • Ypsomed AG
  • Biocon
  • Companion Medical
  • BERLIN CHEMIE AG
  • Eli Lilly and Company
  • Pendiq
  • Emperra GmbH E-Health Technologies

1. Introduction

1.1 Scope of The Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Insulin Pens Market – By Product Type

1.3.2 Global Insulin Pens Market – By Application

1.3.3 Global Insulin Pens Market – By Distribution Channel

1.3.4 Global Insulin Pen market – By Geography

2. Insulin Pen Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Global Insulin Pens– Market Landscape

4.1 Overview

4.2 Pest Analysis

4.2.1 North America – PEST Analysis

4.2.2 Europe – PEST Analysis

4.2.3 Asia Pacific – PEST Analysis

4.2.4 Middle East & Africa – PEST Analysis

4.2.5 South & Central America – PEST Analysis

5. Insulin Pens Market – Key Market Dynamics

5.1 Key Market Drivers

5.1.1 Rising Incidence of Diabetes

5.1.2 Growing Geriatric Population

5.1.3 Rising Adoption of Insulin Injection Pens over Vials & Syringes

5.2 Key Market Restraints

5.2.1 Availability of Alternatives for Drug Delivery

5.2.2 Limitations Associated with Insulin Pens

5.3 Key Market Opportunity

5.3.1 Growing Market In Developing Economies

5.4 Future Trend

5.4.1 Growing Product Innovations through Collaborative Research

5.5 Impact Analysis

6. Insulin Pens Market – Global Analysis

6.1 Global Insulin Pens Market Revenue Forecasts And Analysis

6.2 Global Insulin Pens Market, By Geography - Forecasts And Analysis

6.3 Performance of Key Players

6.3.1 Novo Nordisk A/S

6.3.2 Eli Lilly and Company

7. Global Insulin Pens Market Analysis And Forecasts To 2027 – Product Type

7.1 Overview

7.2 Insulin Pens Market Revenue And Forecasts Analysis, By Product Type (US$ Mn)

7.3 Reusable Market

7.3.1 Overview

7.3.2 Global Reusable Market Revenue and Forecast to 2027 (US$ Mn)

7.4 Disposable Market

7.4.1 Overview

7.4.2 Global Disposable Market Revenue and Forecast to 2027 (US$ Mn)

7.5 Smart Insulin Pen Caps Market

7.5.1 Overview

7.5.2 Global Smart Insulin Pen Caps Market Revenue and Forecast to 2027 (US$ Mn)

8. Global Insulin Pens Market Analysis And Forecasts To 2027 – Application

8.1 Overview

8.2 Insulin Pens Market Revenue And Forecasts Analysis, By Application (US$ Mn)

8.3 Type-1 Diabetes Market

8.3.1 Overview

8.3.2 Global Type-1 Diabetes Market Revenue and Forecast to 2027 (US$ Mn)

8.4 Type-2 Diabetes Market

8.4.1 Overview

8.4.2 Global Type-2 Diabetes Market Revenue and Forecast to 2027 (US$ Mn)

9. Global Insulin Pens Market Analysis – By Distribution Channel

9.1 Overview

9.2 Insulin Pens Market Revenue And Forecasts Analysis, By Distribution Channel (US$ Mn)

9.3 Hospitals Pharmacies Market

9.3.1 Overview

9.3.2 Global Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

9.4 Retail Pharmacies Market

9.4.1 Overview

9.4.2 Global Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

9.5 E-Commerce Market

9.5.1 Overview

9.5.2 Global e-Commerce Market Revenue and Forecasts to 2027 (US$ Mn)

10. Insulin Pens Market Revenue And Forecasts To 2027 – Geographical Analysis

10.1 North America Insulin Pens Market

10.1.1 Overview

10.1.2 North America Insulin Pens Market Revenue And Forecasts to 2027 (US$ MN)

10.1.3 North America Insulin Pens Market Revenue And Forecasts to 2027, By Product Type (US$ Mn)

10.1.4 North America Insulin Pens Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.1.5 North America Insulin Pens Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.1.6 North America Insulin Pens Market Revenue and Forecasts to 2027, By Country (%)

10.1.7 US Insulin Pens Market

10.1.7.1 US Insulin Pens Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.7.2 US Insulin Pens Market Revenue And Forecasts to 2027, By Product Type (US$ Mn)

10.1.7.3 US Insulin Pens Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.1.7.4 US Insulin Pens Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.1.8 Canada Insulin Pens Market

10.1.8.1 Canada Insulin Pens Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.8.2 Canada Insulin Pens Market Revenue And Forecasts to 2027, By Product Type (US$ Mn)

10.1.8.3 Canada Insulin Pens Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.1.8.4 Canada Insulin Pens Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.1.9 Mexico Insulin Pens Market

10.1.9.1 Mexico Insulin Pens Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.9.2 Mexico Insulin Pens Market Revenue And Forecasts to 2027, By Product Type (US$ Mn)

10.1.9.3 Mexico Insulin Pens Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.1.9.4 Mexico Insulin Pens Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.2 Europe Insulin Pens Market

10.2.1 Overview

10.2.2 Europe Insulin Pens Market Revenue And Forecasts to 2027 (US$ Mn)

10.2.3 Europe Insulin Pens Market Revenue And Forecasts to 2027, By Product Type (US$ Mn)

10.2.4 Europe Insulin Pens Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.2.5 Europe Insulin Pens Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.2.6 Europe Insulin Pens Market Revenue and Forecasts to 2027, By Country (%)

10.2.7 Germany Insulin Pens Market

10.2.7.1 Germany Insulin Pens Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.7.2 Germany Insulin Pens Market Revenue And Forecasts to 2027, By Product Type (US$ Mn)

10.2.7.3 Germany Insulin Pens Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.2.7.4 Germany Insulin Pens Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.2.8 UK Insulin Pens Market

10.2.8.1 UK Insulin Pens Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.8.2 UK Insulin Pens Market Revenue And Forecasts to 2027, By Product Type (US$ Mn)

10.2.8.3 UK Insulin Pens Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.2.8.4 UK Insulin Pens Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.2.9 France Insulin Pens Market

10.2.9.1 France Insulin Pens Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.9.2 France Insulin Pens Market Revenue And Forecasts to 2027, By Product Type (US$ Mn)

10.2.9.3 France Insulin Pens Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.2.9.4 France Insulin Pens Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.2.10 Spain Insulin Pens Market

10.2.10.1 Spain Insulin Pens Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.10.2 Spain Insulin Pens Market Revenue And Forecasts to 2027, By Product Type (US$ Mn)

10.2.10.3 Spain Insulin Pens Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.2.10.4 Spain Insulin Pens Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.2.11 Italy Insulin Pens Market

10.2.11.1 Italy Insulin Pens Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.11.2 Italy Insulin Pens Market Revenue And Forecasts to 2027, By Product Type (US$ Mn)

10.2.11.3 Italy Insulin Pens Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.2.11.4 Italy Insulin Pens Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.3 Asia Pacific Insulin Pens Market

10.3.1 Overview

10.3.2 Asia Pacific Insulin Pens Market Revenue And Forecasts to 2027 (US$ Mn)

10.3.3 Asia Pacific Insulin Pens Market Revenue And Forecasts to 2027, By Product Type (US$ Mn)

10.3.4 Asia Pacific Insulin Pens Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.3.5 Asia Pacific Insulin Pens Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.3.6 Asia Pacific Insulin Pens Market Revenue and Forecasts to 2027, By Country (%)

10.3.7 China Insulin Pens Market

10.3.7.1 China Insulin Pens Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.7.2 China Insulin Pens Market Revenue And Forecasts to 2027, By Product Type (US$ Mn)

10.3.7.3 China Insulin Pens Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.3.7.4 China Insulin Pens Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.3.8 Japan Insulin Pens Market

10.3.8.1 Japan Insulin Pens Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.8.2 Japan Insulin Pens Market Revenue And Forecasts to 2027, By Product Type (US$ Mn)

10.3.8.3 Japan Insulin Pens Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.3.8.4 Japan Insulin Pens Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.3.9 India Insulin Pens Market

10.3.9.1 India Insulin Pens Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.9.2 India Insulin Pens Market Revenue And Forecasts to 2027, By Product Type (US$ Mn)

10.3.9.3 India Insulin Pens Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.3.9.4 India Insulin Pens Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.3.10 Australia Insulin Pens Market

10.3.10.1 Australia Insulin Pens Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.10.2 Australia Insulin Pens Market Revenue And Forecasts to 2027, By Product Type (US$ Mn)

10.3.10.3 Australia Insulin Pens Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.3.10.4 Australia Insulin Pens Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.3.11 South Korea Insulin Pens Market

10.3.11.1 South Korea Insulin Pens Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.11.2 South Korea Insulin Pens Market Revenue And Forecasts to 2027, By Product Type (US$ Mn)

10.3.11.3 South Korea Insulin Pens Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.3.11.4 South Korea Insulin Pens Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.4 Middle East And Africa Insulin Pens Market

10.4.1 Overview

10.4.2 Middle East & Africa Insulin Pens Market Revenue And Forecasts to 2027 (US$ Mn)

10.4.3 Middle East & Africa Insulin Pens Market Revenue And Forecasts to 2027, By Product Type (US$ Mn)

10.4.4 Middle East & Africa Insulin Pens Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.4.5 Middle East & Africa Insulin Pens Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.4.6 Middle East & Africa Insulin Pens Market Revenue and Forecasts to 2027, By Country (%)

10.4.7 UAE Insulin Pens Market

10.4.7.1 UAE Insulin Pens Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.7.2 UAE Insulin Pens Market Revenue And Forecasts to 2027, By Product Type (US$ Mn)

10.4.7.3 UAE Insulin Pens Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.4.7.4 UAE Insulin Pens Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.4.8 Saudi Arabia Insulin Pens Market

10.4.8.1 Saudi Arabia Insulin Pens Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.8.2 Saudi Arabia Insulin Pens Market Revenue And Forecasts to 2027, By Product Type (US$ Mn)

10.4.8.3 Saudi Arabia Insulin Pens Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.4.8.4 Saudi Arabia Insulin Pens Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.4.9 South Africa Insulin Pens Market

10.4.9.1 South Africa Insulin Pens Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.9.2 South Africa Insulin Pens Market Revenue And Forecasts to 2027, By Product Type (US$ Mn)

10.4.9.3 South Africa Insulin Pens Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.4.9.4 South Africa Insulin Pens Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.5 South And Central America Insulin Pens Market

10.5.1 Overview

10.5.2 South & Central America Insulin Pens Market Revenue And Forecasts to 2027 (US$ Mn)

10.5.3 South & Central America Insulin Pens Market Revenue And Forecasts to 2027, By Product Type (US$ Mn)

10.5.4 South & Central America Insulin Pens Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.5.5 South & Central America Insulin Pens Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.5.6 South & Central America Insulin Pens Market Revenue and Forecasts to 2027, By Country (%)

10.5.7 Brazil Insulin Pens Market

10.5.7.1 Brazil Insulin Pens Market Revenue and Forecasts to 2027 (US$ Mn)

10.5.7.2 Brazil Insulin Pens Market Revenue And Forecasts to 2027, By Product Type (US$ Mn)

10.5.7.3 Brazil Insulin Pens Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.5.7.4 Brazil Insulin Pens Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.5.8 Argentina Insulin Pens Market

10.5.8.1 Argentina Insulin Pens Market Revenue and Forecasts to 2027 (US$ Mn)

10.5.8.2 Argentina Insulin Pens Market Revenue And Forecasts to 2027, By Product Type (US$ Mn)

10.5.8.3 Argentina Insulin Pens Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.5.8.4 Argentina Insulin Pens Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

11. Insulin Pens Market – Industry Landscape

11.1 Overview

11.2 Comparative Company Analysis

11.3 Growth Strategies Done By The Companies In The Market, (%)

11.4 Organic Developments

11.4.1 Overview

11.5 Inorganic Developments

11.5.1 Overview

12. Insulin Pens Market – Key Company Profiles

12.1 Owen Mumford, Ltd.

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Financial Overview

12.1.4 Product Portfolio

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Novo Nordisk A/S

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Financial Overview

12.2.4 Product Portfolio

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Companion Medical

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Financial Overview

12.3.4 Product Portfolio

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Berlin-Chemie Ag

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Financial Information

12.4.4 Product Portfolio

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Pendiq Gmbh

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Financial Information

12.5.4 Product Portfolio

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Emperra Gmbh E-Health Technologies

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Financial Information

12.6.4 Product Portfolio

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Eli Lilly And Company

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Financial Overview

12.7.4 Product Portfolio

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 Ypsomed Ag

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Financial Overview

12.8.4 Product Portfolio

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Sanofi

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Financial Overview

12.9.4 Product portfolio

12.9.5 SWOT ANALYSIS

12.9.6 KEY DEVELOPMENTS

12.10 Biocon

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Financial Overview

12.10.4 Product Portfolio

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary Of Terms

LIST OF TABLES

Table 1. Prevalence of Diabetes Worldwide, 2017

Table 2. Total Number of Persons Aged 60 Years or Above By Region, 2017 & 2050

Table 3. North America Insulin Pens Market Revenue And Forecasts To 2027, By Product Type (US$ Mn)

Table 4. North America Insulin Pens Market Revenue And Forecasts To 2027, By Application (US$ Mn)

Table 5. North America Insulin Pens Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)

Table 6. US Insulin Pens Market Revenue And Forecasts To 2027, By Product Type (US$ Mn)

Table 7. US Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Application (US$ Mn)

Table 8. US Insulin Pens Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)

Table 9. Canada Insulin Pens Market Revenue And Forecasts To 2027, By Product Type (US$ Mn)

Table 10. Canada Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Application (US$ Mn)

Table 11. Canada Insulin Pens Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)

Table 12. Mexico Insulin Pens Market Revenue And Forecasts To 2027, By Product Type (US$ Mn)

Table 13. Mexico Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Application (US$ Mn)

Table 14. Mexico Insulin Pens Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)

Table 15. Europe Insulin Pens Market Revenue And Forecasts To 2027, By Product Type (US$ Mn)

Table 16. Europe Insulin Pens Market Revenue And Forecasts To 2027, By Application (US$ Mn)

Table 17. Europe Insulin Pens Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)

Table 18. Germany Insulin Pens Market Revenue And Forecasts To 2027, By Product Type (US$ Mn)

Table 19. Germany Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Application (US$ Mn)

Table 20. Germany Insulin Pens Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)

Table 21. UK Insulin Pens Market Revenue And Forecasts To 2027, By Product Type (US$ Mn)

Table 22. UK Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Application (US$ Mn)

Table 23. UK Insulin Pens Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)

Table 24. France Insulin Pens Market Revenue And Forecasts To 2027, By Product Type (US$ Mn)

Table 25. France Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Application (US$ Mn)

Table 26. France Insulin Pens Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)

Table 27. Spain Insulin Pens Market Revenue And Forecasts To 2027, By Product Type (US$ Mn)

Table 28. Spain Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Application (US$ Mn)

Table 29. Spain Insulin Pens Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)

Table 30. Italy Insulin Pens Market Revenue And Forecasts To 2027, By Product Type (US$ Mn)

Table 31. Italy Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Application (US$ Mn)

Table 32. Italy Insulin Pens Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)

Table 33. Asia Pacific Insulin Pens Market Revenue And Forecasts To 2027, By Product Type (US$ Mn)

Table 34. Asia Pacific Insulin Pens Market Revenue And Forecasts To 2027, By Application (US$ Mn)

Table 35. Asia Pacific Insulin Pens Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)

Table 36. China Insulin Pens Market Revenue And Forecasts To 2027, By Product Type (US$ Mn)

Table 37. China Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Application (US$ Mn)

Table 38. China Insulin Pens Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)

Table 39. Japan Insulin Pens Market Revenue And Forecasts To 2027, By Product Type (US$ Mn)

Table 40. Japan Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Application (US$ Mn)

Table 41. Japan Insulin Pens Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)

Table 42. India Insulin Pens Market Revenue And Forecasts To 2027, By Product Type (US$ Mn)

Table 43. India Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Application (US$ Mn)

Table 44. India Insulin Pens Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)

Table 45. Australia Insulin Pens Market Revenue And Forecasts To 2027, By Product Type (US$ Mn)

Table 46. Australia Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Application (US$ Mn)

Table 47. Australia Insulin Pens Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)

Table 48. South Korea Insulin Pens Market Revenue And Forecasts To 2027, By Product Type (US$ Mn)

Table 49. South Korea Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Application (US$ Mn)

Table 50. South Korea Insulin Pens Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)

Table 51. Middle East & Africa Insulin Pens Market Revenue And Forecasts To 2027, By Product Type (US$ Mn)

Table 52. Middle East & Africa Insulin Pens Market Revenue And Forecasts To 2027, By Application (US$ Mn)

Table 53. Middle East & Africa Insulin Pens Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)

Table 54. UAE Insulin Pens Market Revenue And Forecasts To 2027, By Product Type (US$ Mn)

Table 55. UAE Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Application (US$ Mn)

Table 56. UAE Insulin Pens Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)

Table 57. Saudi Arabia Insulin Pens Market Revenue And Forecasts To 2027, By Product Type (US$ Mn)

Table 58. Saudi Arabia Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Application (US$ Mn)

Table 59. Saudi Arabia Insulin Pens Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)

Table 60. South Africa Insulin Pens Market Revenue And Forecasts To 2027, By Product Type (US$ Mn)

Table 61. South Africa Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Application (US$ Mn)

Table 62. South Africa Insulin Pens Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)

Table 63. South & Central America Insulin Pens Market Revenue And Forecasts To 2027, By Product Type (US$ Mn)

Table 64. South & Central America Insulin Pens Market Revenue And Forecasts To 2027, By Application (US$ Mn)

Table 65. South & Central America Insulin Pens Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)

Table 66. Brazil Insulin Pens Market Revenue And Forecasts To 2027, By Product Type (US$ Mn)

Table 67. Brazil Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Application (US$ Mn)

Table 68. Brazil Insulin Pens Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)

Table 69. Argentina Insulin Pens Market Revenue And Forecasts To 2027, By Product Type (US$ Mn)

Table 70. Argentina Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Application (US$ Mn)

Table 71. Argentina Insulin Pens Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)

Table 72. Organic Developments Done By Companies

Table 73. Inorganic Developments Done By Companies

Table 74. Glossary of Terms, Insulin Pens Market

LIST OF FIGURES

Figure 1. Insulin Pen Market Segmentation

Figure 2. Insulin Pen Market Segmentation, By Region

Figure 3. Global Insulin Pen Market Overview

Figure 4. Reusable Segment Held Largest Share Of Product Type Segment In Insulin Pen Market

Figure 5. Asia Pacific Region is Expected to Show Remarkable Growth During the Forecast Period

Figure 6. Global Insulin Pen Market, By Geography (US$ Mn)

Figure 7. Global Insulin Pen Market- Leading Country Markets (US$ Mn)

Figure 8. Global Insulin Pen Market, Industry Landscape

Figure 9. North America Pest Analysis

Figure 10. Europe Pest Analysis

Figure 11. Asia Pacific Pest Analysis

Figure 12. Middle East & Africa Pest Analysis

Figure 13. South & Central America Pest Analysis

Figure 14. Insulin Pens Market Impact Analysis Of Driver And Restraints

Figure 15. Global Insulin Pens Market – Revenue Forecasts And Analysis –2018- 2027

Figure 16. Global Insulin Pens Market – By Geography Forecasts And Analysis – 2018- 2027

Figure 17. Insulin Pens Market Revenue and Forecast Analysis, By Product Type 2018 And 2027 (%)

Figure 18. Global Reusable Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 19. Global Disposable Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 20. Global Smart Insulin Pen Caps Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 21. Insulin Pens Market Revenue and Forecast Analysis, By Application 2018 and 2027 (%)

Figure 22. Global Type-1 Diabetes Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 23. Global Type-2 Diabetes Market Revenue and Forecasts To 2027 (US$ Mn)

Figure 24. Global Insulin Pens Market Revenue and Forecast Analysis, By Distribution Channel 2018 & 2027 (%)

Figure 25. Global Hospital Pharmacies Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 26. Global Retail Pharmacies Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 27. Global E-Commerce Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 28. North America Insulin Pens Market Revenue Overview, By Country (2018) (US$ Mn)

Figure 29. North America Insulin Pens Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 30. North America Insulin Pens Market Revenue and Forecasts To 2027, By Country (%)

Figure 31. US Insulin Pens Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 32. Canada Insulin Pens Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 33. Mexico Insulin Pens Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 34. Europe Insulin Pens Market Revenue Overview, By Country (2018) (Us $ Mn)

Figure 35. Europe Insulin Pens Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 36. Europe Insulin Pens Market Revenue and Forecasts To 2027, By Country (%)

Figure 37. Germany Insulin Pens Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 38. UK Insulin Pens Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 39. France Insulin Pens Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 40. Spain Insulin Pens Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 41. Italy Insulin Pens Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 42. Asia Pacific Insulin Pens Market Revenue Overview, By Country (2018) (Us $ Mn)

Figure 43. Asia Pacific Insulin Pens Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 44. Asia Pacific Insulin Pens Market Revenue and Forecasts To 2027, By Country (%)

Figure 45. China Insulin Pens Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 46. Japan Insulin Pens Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 47. India Insulin Pens Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 48. Australia Insulin Pens Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 49. South Korea Insulin Pens Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 50. Middle East & Africa Insulin Pens Market Revenue Overview, By Country (2018) (US$ Mn)

Figure 51. Middle East & Africa Insulin Pens Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 52. Middle East & Africa Insulin Pens Market Revenue and Forecasts To 2027, By Country (%)

Figure 53. UAE Insulin Pens Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 54. Saudi Arabia Insulin Pens Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 55. South Africa Insulin Pens Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 56. South & Central America Insulin Pens Market Revenue Overview, By Country (2018) (Us $ Mn)

Figure 57. South & Central America Insulin Pens Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 58. South & Central America Insulin Pens Market Revenue and Forecasts To 2027, By Country (%)

Figure 59. Brazil Insulin Pens Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 60. Argentina Insulin Pens Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 61. Comparative Company Analysis

Figure 62. Growth Strategies Done By The Companies In The Market, (%)

The List of Companies - Insulin Pens Market

  1. Novo Nordisk A/S
  2. Owen Mumford
  3. Sanofi
  4. Ypsomed AG
  5. Biocon
  6. Companion Medical
  7. BERLIN CHEMIE AG
  8. Eli Lilly and Company
  9. Pendiq GmbH
  10. Emperra GmbH E-Health Technologies
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the insulin pens market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global insulin pens market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPRE00004650
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Frequently Asked Questions

Insulin pens are devices used for the diabetes patients to inject the insulin in the patient’s body in desired quantity. The insulin pen is slightly larger than the writing pen in size and it contains the insulin in the refill. Insulin pens have made it convenient and less painful for the diabetic patients to take insulin. Not only insulin pen injects precise amount of insulin in the body but also it may be done in fewer steps than syringe.

Driving factors such as, rising incidence of diabetes, growing geriatric population, inclination towards insulin pens over conventional needles & syringes in insulin pens are expected to boost the market growth over the years. However, alternatives to pens for insulin administration and limitation associated with the insulin pens are likely to hamper the market growth. However, growing market in developing regions are likely to deliver substantial growth opportunities to improve market share for industry players in the near future.

The price of insulin pens lies between the ranges of US$ 40-100 per unit. However, the cost profoundly differs based upon the function, brand and features of the insulin pen. Also, the cost of these pens depends based on the location of the manufacturer depending upon the regulatory reforms and the demand for the products.

Pricing
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.